Skip to content

Deargen vs Protai

Deargen logo

Deargen

AI-First Pharmatech Company. We are exploring sequence-based drug discovery and development

9 employees · est. 2016 · Daejeon, Korea South

VS
Protai logo

Protai

Unlocking the therapeutic potential of protein complexes with the power of structural proteomics and AI

29 employees · est. 2021 · Israel

Deargen is the older company (2016 vs 2021); Protai is the larger of the two.

Side-by-Side Comparison

Deargen Protai
Founded
2016 older 2021
Headquarters
Daejeon, Korea South Israel
Employees
9 29 larger
Industry
AI, Biotechnology, Machine Learning AI, Biotechnology, Life Sciences
Funding Stage
Series B Seed
Total Funding
$23.00B $20.00M
Funding Rounds
3 2
Services
AI Platform for Drug Discovery, New Drug Development, Molecular Optimization, Target Affinity Prediction, Toxicity-Centered Drug Design Structural Proteomics Integration, AI-Driven Drug Discovery, Pipeline Development, End-to-End Drug Discovery Collaboration, AIMS™ Platform Utilization
Target Customers
Pharmaceutical Companies, Biotech Firms, Medical Research Institutions, Drug Development Organizations, AI-Driven Healthcare Providers Pharmaceutical Companies, Biotech Firms, Research Institutions, Healthcare Innovators, Partnering Enterprises
Taxonomy
AI-driven Drug DiscoverySequence-based Drug DevelopmentTransformer Technology In PharmaceuticalsHit/Lead Compound DiscoveryEnd-to-end AI SolutionBiotechnology Innovation +9 ProteomicsAI Drug DiscoveryEnd-to-End AI PlatformCellular Function AnalysisBiological InsightsComplex Disease Combat +8
Website
deargen.me protai.bio
Deargen logo

About Deargen

Deargen, founded in 2016, positions itself as a pioneer in the intersection of AI and pharmaceuticals. This AI-First Pharmatech Company focuses on revolutionizing drug discovery and development through sequence-based AI solutions. Headquartered in Korea South, the company leverages advanced AI, part...

Protai logo

About Protai

Protai, founded in 2021 and headquartered in Israel, leverages cutting-edge technologies in AI, Biotechnology, and Life Sciences to revolutionize drug discovery. By utilizing an AI-based platform, Protai delves into the proteomic landscape to map diseases at the protein level, offering a novel appro...

Also comparing in this category

Comparing more than these two?

Get Deargen, Protai and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does Deargen compare?

A PDF of Deargen and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

Deargen was founded in 2016, based in Daejeon, Korea South, with 9 employees. Deargen, founded in 2016, positions itself as a pioneer in the intersection of AI and pharmaceuticals. This AI-First Pharmatech Company focuses on revolutionizing drug discovery and development throug. Protai was founded in 2021, based in Israel, with 29 employees. Protai, founded in 2021 and headquartered in Israel, leverages cutting-edge technologies in AI, Biotechnology, and Life Sciences to revolutionize drug discovery. By utilizing an AI-based platform, Pro.
Deargen has raised $23.00B and Protai $20.00M. Latest stage: Deargen Series B, Protai Seed.
Both work in AI and Biotechnology.

Compare Deargen with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Deargen on 15 Jun 2026, and Protai on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout